跳至主要内容
临床试验/NCT05701085
NCT05701085招募中不适用

Prospective Cohort Study of a Patient Navigator PRE-ACT Educational Intervention to Promote Decision Making About Clinical Trials Among Racial and Ethnic Minorities

Case Comprehensive Cancer Center2 个研究点 分布在 1 个国家目标入组 240 人开始时间: 2023年4月24日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
240
试验地点
2
主要终点
Change in knowledge regarding cancer clinical trials after the intervention

研究概览

简要总结

This study focuses on psychosocial barriers at the patient level with the goal of promoting high quality decision making around clinical trials participation. The proposed study adapts the PRE-ACT model to racial and ethnic minority patients who were underrepresented in the original PRE-ACT study and will be combined with a patient navigator model.

详细描述

The primary objective of the proposed research is to employ a non-directive method to improve preparedness for consideration of clinical trials among racial minority patients by providing tailored information to address knowledge and attitudes towards clinical trials. This model has been previously studied in a primarily white, well-educated population. It is unknown how well this model adapts to meet the needs of diverse patient populations.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants must have a diagnosis of either advanced (metastatic) cancer or early stage disease for which they are undergoing oncological work-up, treatment or surveillance
  • Participants must be at least 18 years of age
  • Participants have a non-white race or Hispanic ethnicity recorded in their patient demographics in the electronic medical record
  • Participant must have a life expectancy greater than three months based on the primary oncology team's clinical assessment.
  • Participants must be able to read and verbally communicate in English.
  • Participants must provide written informed consent.

排除标准

  • 未提供

研究组 & 干预措施

PRE-ACT Adaptation

Experimental

At the scheduled oncologic visit: consent obtained and all participants will complete the Demographics/Clinical Characteristics survey and Pre-Intervention Survey

Within 3 months of consent: tailored educational intervention and patient navigation program will take place and the scored Pre-Intervention survey will be used to generate a list of barrier for each patient. The patient will be asked to view educational videos on an iPad that correspond with each identified barrier. Afterwards, the patient navigator will lead a discussion based on the topics discussed.

Within 4 weeks of the educational video: the participant will be contacted via phone to complete a Post-Intervention Survey that assesses knowledge, attitudes, and preparation related to participation in clinical trials

Two years after intervention: chart review will be performed to assess if the patient participated in a clinical trial.

干预措施: Educational Intervention (Other)

结局指标

主要结局

Change in knowledge regarding cancer clinical trials after the intervention

时间窗: Up to 4 months

Change in knowledge regarding cancer clinical trials after the intervention will be assessed by change in Pre and Post Intervention Survey Knowledge Score (scored from Items 1-8) with a higher score correlating to a greater change in knowledge.

Change in attitudes regarding cancer clinical trials after the intervention

时间窗: Up to 4 months

A change in attitude will be recorded using changes in Pre and Post Intervention Survey Attitude Scores (scored from Items 9-21) with a higher score correlating to a greater change in attitude.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验